It is no understatement that every company or provider that handles controlled substances cannot do without compliance training. Coaching from experts can keep them from inadvertently contravening the law! Medicinal drugs play a crucial role in keeping mankind healthy – they can cure sickness, treat diseases and even prevent various afflictions. However, some of the drugs also have a high potential for abuse. The danger lies in unwarranted or excessive use which can lead to severe psychological or physical dependence. This is not just about heroin or marijuana, even Xanax, Valium, Tramadol and Lomotil contain small doses of narcotics that can be misused by careless or unscrupulous elements. Therefore, they are classified as controlled substances with the pertaining laws and regulations being enforced by the DEA. This opens up a veritable minefield of procedures and protocols which can get quite confusing for both large corporations and small setups alike. DEA compliance training is the answer for organizations and individuals to stay in accordance with the law and avoid legal complications in the future. Let us take a look at how the training can help:
The Titan Group can be your partner in ensuring full compliance with the legal requirements and responsibilities of dealing with controlled substances. The DEA compliance training is administered by retired or ex-DEA special agents who are primed to deliver a comprehensive understanding of the law and regulations to the entire staff along with proactive measures to detect and prevent controlled substance diversion. Post-remediation training is also available to ensure that the business stays on the beat with procedural changes, trends and other issues.
0 Comments
The United States holds a conservative approach to the study and use of cannabis. The good news is that it has softened regulations for research and is open to new findings. Let us look at the DEA compliance and regulations. Cannabis is an extremely useful plant whose extracts are proving to be highly beneficial for various ailments. The US cannabis policies vary according to different state jurisdictions and conflict with the federal policy which prohibits the production, possession and distribution of cannabis. Thirty-six states have legalized cannabis for medical use in November 2020 as the effect of cannabis has emerged positively for health. However, the legalized cannabis supply is the only way to meet the inconsistencies in the federal and state laws, improve the safety of cannabis use and regularize supply. In the last month, the DEA (Drug Enforcement Administration), increased the amount of cannabis available for scientific research. Issuing an MoE for multiple growers, it stated that their initiatives agree with the federal law and are in compliance with the regulations that extend its concern on production and research. This is a positive step and growers are hugely encouraged to think of profitable business ventures by growing cannabis for research. However, the formalities for attaining the DEA controlled substance regulations remain the same as before for the production and the growth of cannabis. This is a huge step, as cannabis research was not receiving its full exploration owing to the pace of cannabis legalization. Allowing one production facility, had staggered scientific advancement, and one-third of the American population was already allowed cannabis legally, but very little scientific advancement has been made when compared to alcohol and opiates. Earlier research in public universities could not use cannabis, as it was not grown by the government. Therefore, federal funds could not be dispensed as that would be illegal. They choose cannabis from state-licensed dispensaries. That will still be the case however, more cannabis from a larger community of growers will not just bring diversity in production but knowledge too. The DEA will comply with all the requirements of the controlled substance regulations which include consistency and treaty obligations. They would amend the regulations for bulk growers, manufacturers and add provisions related to the purchase and sale of cannabis or marijuana of those who register with DEA. DEA will vet applicants after its 303 investigations, which is the formal process of investigation before it awards a license to the applicants. The strict guidelines must be understood and followed before submitting the filing to the FDA. Therefore, growers must abide by the procedure and ensure that they can procure this license. If you want a hand-holding that ensures you will be able to sail through the DEA controlled substance regulations, visit https://titangroupdea.com/. Working with retired DEA agents, they have experience and know well what is required to meet the DEA requirements. They will guide you through mock inspections and certification that will help you upgrade conformity standards and keep your farms and books ready for anytime inspection from the DEA. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
April 2023
Categories |